All issues

List of references:

1. J. Angel, M. A. Franco, H. B. Greenberg. Rotavirus vaccines: recent developments and future considerations // Nat. Rev. Microbiol. — 2007. — V. 5. — P. 529–539. — DOI: 10.1038/nrmicro1692.
2. J. R. Beck, S. G. Pauker. The Markov process in medical prognosis // Med Decis Making. — 3. — P. 419–458.
3. M. M. Cortese, U. D. Parashar. Prevention of rotavirus gastroenteritis among infants and children: recommendations of the advisory committee on immunization practices (ACIP) // MMWR Recomm Rep. — 2009. — V. 58. — P. 1–25.
4. R. Glass, U. Parashar, J. Bresee, et al. Rotavirus vaccines: current prospects and future challenges // Lancet. — 2006. — V. 368. — P. 323–32. — DOI: 10.1016/S0140-6736(06)68815-6.
5. Global Advisory Committee on Vaccine Safety, 17–18 December 2008 // Wkly Epidemiol Rec. — 2009. — V. 84. — P. 37–40.
6. K. Grimwood, S. B. Lambert. Rotavirus vaccines: opportunities and challenges // Hum Vaccin. — 2009. — V. 5. — P. 57–69. — PubMed. — DOI: 10.4161/hv.5.2.6924.
7. A. C. Linhares, F. R. Velazquez, I. Perez-Schael, X. Saez-Llorens, H. Abate, F. Espinoza, et al. Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2years of life in Latin American infants: a randomised, double-blind, placebocontrolled phase III study // Lancet. — 2008. — V. 371. — P. 1181–9. — DOI: 10.1016/S0140-6736(08)60524-3.
8. P. Lopez, A. Linhares, I. Perez-Schael, G. Ruiz-Palacios, S. Costa Clemens, N. Sanchez, et al. Early protection against severe rotavirus gastroenteritis–RIX4414 experience in Latin America / 24th Annual Meeting of the European Society of Infectious Diseases. — 2006. — 2006 May 3–5. Basel, Switzerland.
9. Ministry of Health of Ukraine, the Order No. 595. “Regime of preventive vaccinations in Ukraine and quality control and treatment of immunological preparations”. — http://old.moz.gov.ua/ua/portal/dn_20110916_595.html.
10. I. Ogilvie, H. Khoury, El. Khoury A. C. , M. M. Goetghebeur. Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe: serotype distribution and burden of illness // Hum. Vaccin. — 2011. — V. 7, no. 5. — P. 523–33. — Epub 2011 May 1. — DOI: 10.4161/hv.7.5.14819.
11. U. D. Parashar, C. J. Gibson, J. S. Bresse, R. I. Glass. Rotavirus and severe childhood diarrhea // Emerg. Infect. Dis. — 2006. — no. 12. — P. 304–306. — DOI: 10.3201/eid1202.050006.
12. U. D. Parashar, A. Burton, C. Lanata, C. Boschi-Pinto, K. Shibuya, D. Steele, et al. Global mortality associated with rotavirus disease among children in 2004 // J Infect Dis. — 2009. — V. 200. — P. 9–15. — DOI: 10.1086/605025.
13. U. D. Parashar, E. G. Hummelman, J. S. Bresee, M. A. Miller, R. I. Glass. Global illness and deaths caused by rotavirus disease in children // Emerg Infect Dis. — 2003. — V. 9. — P. 565–572. — DOI: 10.3201/eid0905.020562.
14. PubMed. — http://www.ncbi.nlm.nih.gov/pubmed/.
15. J. Rose, R. L. Hawthorn, B. Watts, M. E. Singer. Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis // BMJ. — 2009. — V. 339. — P. b3653. — DOI: 10.1136/bmj.b3653.
16. J. Rose, M. E. Singer. Projecting vaccine efficacy: accounting for geographic strain variations // Pharmacoeconomics. — 2008. — V. 26, no. 3. — P. 185–9. — DOI: 10.2165/00019053-200826030-00003.
17. G. M. Ruiz-Palacios, I. Perez-Schael, F. R. Velazquez, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis // N. Engl. J. Med. — 2006. — V. 354, no. 1. — P. 11–22. — DOI: 10.1056/NEJMoa052434.
18. T. Ruuska, T. Vesikari. Rotavirus disease in Finnish children: use of numerical scores forclinical severity ofdiarrhoeal episodes // Scand. J. Infect. Dis. — 1990. — V. 22. — P. 259–67. — DOI: 10.3109/00365549009027046.
19. B. Salinas, I. Perez Schael, A. C. Linhares, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants // Pediatr. Infect. Dis. J. — 2005. — V. 24, no. 9. — P. 807–16. — DOI: 10.1097/01.inf.0000178294.13954.a1.
20. S. Solovyov, O. Trokhimenko, I. Dzyublyk. Molecular typing of rotaviruses, isolated on the territory of Ukraine // Clinical microbiology and infection. — Special Issue: Abstracts of the 21 st. ECCMID/27th ICC. — V. 17, no. Supplements 4. — Milan, Italy, 7–10 May 2011. — S735.
21. F. A. Sonnenberg, J. R. Beck. Markov models in medical decision making: A practical guide // Med Decis Making. — 1993. — V. 13. — P. 322–338. — DOI: 10.1177/0272989X9301300409.
22. M. Soriano-Gabarro, J. Mrukowicz, T. Vesikari, T. Verstraeten. Burden of rotavirus disease in European Union countries // Pediatr Infect Dis J. — 2006. — V. 25. — P. 7–11.
23. M. Soriano-Gabarro, J. Mrukowicz, T. Vesikari, T. Verstraeten. Burden of rotavirus disease in European Union countries // Pediatr. Infect. Dis. J. — 2006. — V. 25. — P. 7–11.
24. F. R. Velazquez, D. O. Matson, J. J. Calva, L. Guerrero, A. L. Morrow, S. Carter-Campbell, et al. Rotavirus infections in infants as protection against subsequent infections // N. Engl. J. Med. — 1996. — V. 335. — P. 1022–8. — DOI: 10.1056/NEJM199610033351404.
25. T. Vesikari, A. Karvonen, L. Puustinen, et al. Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants // Pediatr. Infect. Dis. J. — 2004. — V. 23, no. 10. — P. 937–43. — DOI: 10.1097/01.inf.0000141722.10130.50.
26. World Health Organization. Immunization profile – Ukraine. — Geneva: WHO, 2008. — http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tscoveragebycountry.cfm?C=UKR.
27. World Health Organization. World Health Statistics 2011. — Geneva: WHO, 2011. — http://www.who.int/whosis/whostat/2011/en/.
28. World Health Organization. External review of burden of disease attributable to rotavirus. — 2005. — http://www.who.int/immunization_monitoring/burden/Rota_virus_Q5_mortality_estimates_external_review_report_2006_may.pdf.
29. С. О. Крамарев. Гострі кишкові інфекції у дітей: навч.-метод. посіб. для лікарів-інтернів. — К: Червона Рута-Турс, 2007. — 132 с.
30. Н. I. Недашкiвська. Оцiнювання реверсу рангiв в методi аналiзу iєрархiй // Системнi дослiдження та iнформацiйнi технологiї. — 2005. — № 4. — С. 120–130.
31. А. Т. Подколзин, Е. Б. Фенске, Н. Ю. Абрамычева и др. Адаптированная к практическому применению методика [P]G генотипирования ротавирусов группы А / Молекулярная диагностика. – 2007: сб. тр. 6-ой Всерос. науч.-практ. конф. с международным участием. — . — М, 2007. — Т. 3. — С. 284–286.
32. Є. Є. Шунько, І. В. Дзюблик, Л. В. Омельченко, С. О. Соловьев. Ротавіруси групи А та аденовіруси у новонароджених з перинатальною патологією: клініко-вірусологічне спостереження // Соврем. педиатрия. — 2011. — № 2. — С. 89–95.